NEXMED INC
NT 10-K, 1999-04-01
PHARMACEUTICAL PREPARATIONS
Previous: NITINOL MEDICAL TECHNOLOGIES INC, NT 10-K, 1999-04-01
Next: TRANSCANADA CAPITAL, 8-K, 1999-04-01



<PAGE>


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25
                         
                         Commission File Number 000-22245

                           NOTIFICATION OF LATE FILING

(CHECK ONE):  /X/Form 10-K  / /Form 20-F / /Form 11-K / /Form 10-Q / Form N-SAR

                  For Period Ended: DECEMBER 31, 1998

                  /X/ Transition Report on Form 10-K 
                  / / Transition Report on Form 20-F 
                  / / Transition Report on Form 11-K 
                  / / Transition Report on Form 10-Q 
                  / / Transition Report on Form N-SAR
                  For the Transition Period Ended:______________________

- --------------------------------------------------------------------------------

  READ INSTRUCTIONS (ON BACK PAGE) BEFORE PREPARING FORM. PLEASE PRINT OR TYPE
    NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
                   VERIFIED ANY INFORMATION CONTAINED HEREIN.

- --------------------------------------------------------------------------------

If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:

- --------------------------------------------------------------------------------

PART I - REGISTRANT INFORMATION

NexMed, Inc.
- --------------------------------------------------------------------------------
Full Name of Registrant

- --------------------------------------------------------------------------------
Former Name if Applicable

350 Corporate Boulevard
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

Robbinsville, New Jersey  08691
- --------------------------------------------------------------------------------
City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed withoug unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate) |X|

         (a)      The reasons described in reasonable detail in Part III of this
                  form could not be eliminated without unreasonable effort or
                  expense;


<PAGE>


         (b)      The subject annual report, semi-annual report, transition
                  report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion
                  thereof, will be filed on or before the fifteenth calendar day
                  following the prescribed due date; or the subject quarterly
                  report of transaction report on Form 10-Q, or portion thereof
                  will be filed on or before the fifth calendar day following
                  the prescribed due date; and
         (c)      The accountant's statement or other exhibit required by Rule
                  12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.

As a result of time constraints on the Company's personnel in the preparation of
Form 10-KSB, including the consolidation of the foreign operations of the
Company, the Company was unable without unreasonable effort and expense to
supply the Form 10-KSB to the Accountants within a time frame sufficient to
complete their audit and issue their report prior to March 31, 1999.

PART IV - OTHER INFORMATION

(1)      Name and telephone number of person to contact in regard to this
         notification

         Selig D. Sacks, Esq.            (212) 326-0879
         -----------------------------------------------------------------------
              (Name)                     (Area Code)          (Telephone Number)

(2)      Have all other periodic reports required under Section 13 or 15(d) of
         the Securities Exchange Act of 1934 or Section 30 of the Investment
         Company Act of 1940 during the preceding 12 months or for such shorter
         period that the registrant was required to file such report(s) been
         filed? If answer is no, identify report(s). /X/ Yes / / No

(3)      Is it anticipated that any significant change in results of operations
         from the corresponding period for the last fiscal year will be
         reflected by the earnings statements to be included in the subject
         report or portion thereof? / / Yes /X/ No

         If so, attach an explanation of the anticipated change, both
         narratively and quantitatively, and, if appropriate, state the reasons
         why a reasonable estimate of the results cannot be made.



                                  NexMed, Inc.
                  --------------------------------------------
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.


Date:    April 1, 1999                  By:      /s/ Vivian H. Liu
     ----------------------------          -------------------------------------





                                       2


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission